Redeye retains its positive view of Carasent following the solid Q2 report showing 15% organic growth, a higher ARR contribution from Infosolutions than expected, and strong scalability. Our traditional Base Case is unchanged at SEK34 while our new Fair value is SEK30 (see details below), making the Carasent share “Attractively Priced”.
LÄS MER
